Clinical Trials Logo
  1. Home
  2. Osteoporosis, Osteopenia
  3. NCT00330096

Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women

Osteoporosis, Osteopenia Clinical Trial

Clinical Trial Summary

Fruits and vegetables are rich in a variety of flavonoids with antioxidant properties. These compounds may be partially responsible for some of the positive links found between fruits and vegetables intake and higher bone mineral density in adults and children. Several animal studies have shown that consumption of onions (which are rich in quercetin), rutin (a quercetin glycoside) and resvatrol (found in red wine) inhibits ovariectomy induced bone loss in rats. One of the most studied flavonoids with respect to bone health is the soy isoflavones. However, consumption of soy products is relatively low in Western countries. One the other hand, a flavonoid such as hesperidin, found mostly in oranges is much more abundant in the Western diet. Citrus juice consumption has been demonstrated to prevent bone loss in male orchidectomized rats while specifically feeding hesperidin has been shown to prevent bone loss in ovariectomized mice and rats. However, to date no clinical prove has been obtained for these benefits.Therefore the aim of this study is to investigate the effect of hesperidin in preventing bone loss in postmenopausal women. This study is designed as a 2-year, double blind, placebo-controlled, two arm, and parallel group study. The primary outcome measure is change in bone mineral density (BMD) while the secondary outcome measures are changes in bone resorption and formation markers as well as body composition. The women are randomised to consume 2 servings of hesperidin-rich food or food without hesperidin but with the same taste & appearance (placebo). Subjects will undergo medical screening, anthropometry, physical activity, dietary assessments and BMD before randomisation into placebo or active group. Follow-up measurements are made at 3-month intervals (for blood and urine collection) and 6-month intervals for bone mineral density. Side effects are also being monitored during each visit.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00330096
Study type Interventional
Source Nestlé
Contact
Status Completed
Phase Phase 3
Start date March 2006
Completion date April 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT03413540 - Effects of Jumping on Bone Health in Young Women N/A
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Recruiting NCT01844154 - Fracture and Fall Prevention in Elderly With Osteoporosis N/A
Completed NCT04169698 - Alendronate Versus Denosumab in Kidney Transplant Patients Phase 2/Phase 3
Completed NCT03408119 - Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men N/A
Recruiting NCT06305156 - Protocol Optimization in CT for the Quantification of BMD N/A
Completed NCT03026660 - Moringa Oleifera on Bone Density N/A
Completed NCT01153425 - µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis Phase 4
Completed NCT04748250 - Effect of Soy Phytoestrogens and Acupuncture on Bone Mineral Density in Female Athlete Triad at Adolescence Age N/A
Not yet recruiting NCT03518268 - Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor Phase 1/Phase 2
Completed NCT04535180 - Sarcopenia and Osteoporosis in the Patients With Hemophilia
Recruiting NCT05712252 - Risk Factors for Fall and Fracture
Completed NCT03367585 - Effects of Vitamin D Supplementation in Muscle Strength and Balance Training N/A
Completed NCT03091088 - Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women N/A
Recruiting NCT06279078 - Long-term Effect of Steroid on Metabolic Diseases in Asthmatics
Completed NCT04526327 - Osteosarcopenia and Exercise N/A
Recruiting NCT03467035 - Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis N/A
Not yet recruiting NCT04034199 - Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid Phase 3
Completed NCT06359353 - Effect of Pitavastatin on Bone Phase 4
Completed NCT03898024 - Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass N/A